This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Obesity Science & Innovation
September 16-17, 2025
Thomas Michael Menino Convention & Exhibition CenterBoston, US

Steffen-Sebastian Bolz
CSO at Aphaia Pharma
Speaker

Profile

Steffen-Sebastian Bolz is a scientist, physician and entrepreneur. He is a Co-Founder of Aphaia Pharma AG and Founder and Chief Scientific and Medical Officer at Qanatpharma AG. Steffen-Sebastian holds a full professorship at the University of Toronto, is a Principal Investigator at the Ted Rogers Centre for Heart Research and is Director of the Toronto Centre for Microvascular Medicine. His research program has contributed novel signaling paradigms, methodological advancements and validated innovative molecular/therapeutic targets in the emerging field of microvascular medicine. Steffen-Sebastian holds a medical degree and a doctorate from the universities of Lübeck and Munich, Germany.

Agenda Sessions

  • Harnessing Gastrointestinal Nutrient-Sensing for Comprehensive Metabolic Regulation

    09:30